Organon nelle notizie
Terapie e prodotti sanitari
Tamtam ha trovato 20 articoli recenti su Organon.
- Organon Stock: A Merger-Arbitrage Hold With Limited Upside (NYSE:OGN)
- Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
- Henlius
- Sun Pharma completes $11.75bn financing syndication for Organon acquisition
- Organon & Co. Shareholders Clear Sun Pharma Merger Deal
- Organon commits more than $1.3 million towards enabling choices and resilient demographies with UNFPA
- Sun Pharma's Organon deal set to reshape biosimilars competitive landscape
- White & Case advises Sun Pharma on US$11.75 billion acquisition of Organon
- Sun Pharma to buy Organon for more than $11 billion
- Sun Pharma strikes biopharma's largest deal of '26 with $11.75B buyout of Organon
- Organon: Deep Value With No Clear Catalysts (NYSE:OGN)
- Organon & Co. (NYSE:OGN) Given Average Recommendation of "Reduce" by Analysts
- TetraScience and Organon Collaborate to Modernize Quality Control Data Management
- Laborie Expands Portfolio with Acquisition of JADA System from Organon
- Organon Details Nexplanon Sales Practice Issue
- Organon CEO exits, company goes on hunt for successor as internal probe turns up 'improper' Nexplanon sales tactics
- Organon divests Jada System, sends 100 employees to Laborie Medical Technologies in $465M deal
- Organon and Henlius see FDA approval of Poherdy for HER2-positive breast cancers
- Organon and UNFPA advance reproductive health services
- Henlius, Organon win US FDA approval of first Perjeta biosimilar
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Organon?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili